See All Slides - tctmd.com

Slides

Presentation The Structural Heart Disease Summit 2018

Subtotal Left Main Occlusion Two Days After Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis

Presenter: Howard C. Herrmann, Fabian Nietlispach, Futoshi Yamanaka, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

The Clinical Operators Corner: Three Case Examples of Limitations and Frustrations With Current Imaging for Transcatheter Mitral and Tricuspid Procedures

Presenter: Rebecca T. Hahn, Christopher U. Meduri

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cases of Unusual Mechanisms of Coronary Occlusion During TAVR

Presenter: Omar Khalique

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Coronary Occlusion Following Self-Expandable Transcatheter Aortic Valve Replacement in Native Aortic Valve Regurgitation

Presenter: Howard C. Herrmann, Fabian Nietlispach, Mohamad Lazkani, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Large Hole Transfemoral Closure III: The MANTA Device

Presenter: Nicolas M. Van Mieghem

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR Case Selection in the Real World: Based on Society Guidelines OR Risk Models OR Clinical and Anatomic Factors?

Presenter: Allan Schwartz, Stephan Windecker, Neil E. Moat

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Utility of Fusion Imaging Now and in the Future for Transcatheter Mitral and Tricuspid Procedures

Presenter: Rebecca T. Hahn, Dee Dee Wang

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

The New Syndrome of Delayed Coronary Occlusion (DCA) After TAVR: Frequency, Causes, and Outcomes

Presenter: Azeem Latib

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Large Hole Transfemoral Closure II: The InSeal Device

Presenter: Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Acute Left Main Stem Coronary Occlusion Following Transcatheter Aortic Valve Replacement in a Patient Without Recognized Coronary Obstruction Risk Factors

Presenter: Howard C. Herrmann, Fabian Nietlispach, Roberto Spina, MD

June 21, 2018

Advertisement

Slides

Subtotal Left Main Occlusion Two Days After Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis

The Clinical Operators Corner: Three Case Examples of Limitations and Frustrations With Current Imaging for Transcatheter Mitral and Tricuspid Procedures

Cases of Unusual Mechanisms of Coronary Occlusion During TAVR

Coronary Occlusion Following Self-Expandable Transcatheter Aortic Valve Replacement in Native Aortic Valve Regurgitation

Large Hole Transfemoral Closure III: The MANTA Device

TAVR Case Selection in the Real World: Based on Society Guidelines OR Risk Models OR Clinical and Anatomic Factors?

Utility of Fusion Imaging Now and in the Future for Transcatheter Mitral and Tricuspid Procedures

The New Syndrome of Delayed Coronary Occlusion (DCA) After TAVR: Frequency, Causes, and Outcomes

Large Hole Transfemoral Closure II: The InSeal Device

Acute Left Main Stem Coronary Occlusion Following Transcatheter Aortic Valve Replacement in a Patient Without Recognized Coronary Obstruction Risk Factors

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content